High-throughput longitudinal electrophysiology screening of mature chamber-specific hiPSC-CMs using optical mapping

Zhang, 2009, Functional cardiomyocytes derived from human induced pluripotent stem cells, Circ. Res., 104, e30, 10.1161/CIRCRESAHA.108.192237 Thomson, 1998, Embryonic stem cell lines derived from human blastocysts, Science, 282, 1145, 10.1126/science.282.5391.1145 Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 Ahmed, 2020, A Brief Review of Current Maturation Methods for Human Induced Pluripotent Stem Cells-Derived Cardiomyocytes, Front. Cell Dev. Biol., 8, 178, 10.3389/fcell.2020.00178 Blinova, 2018, International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment, Cell Rep., 24, 3582, 10.1016/j.celrep.2018.08.079 da Rocha, 2020, Detection of Drug-Induced Torsades de Pointes Arrhythmia Mechanisms Using hiPSC-CM Syncytial Monolayers in a High-Throughput Screening Voltage Sensitive Dye Assay, Toxicol. Sci., 173, 402, 10.1093/toxsci/kfz235 Yang, 2022, Use of Human iPSC-CMs in Nonclinical Regulatory Studies for Cardiac Safety Assessment, Toxicol. Sci., 190, 117, 10.1093/toxsci/kfac095 Davis, 2021, In vitro model of ischemic heart failure using human induced pluripotent stem cell-derived cardiomyocytes, JCI Insight, 6, e134368, 10.1172/jci.insight.134368 Lan, 2013, Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient-specific induced pluripotent stem cells, Cell Stem Cell, 12, 101, 10.1016/j.stem.2012.10.010 Feng, 2021, Long QT Syndrome KCNH2 Variant Induces hERG1a/1b Subunit Imbalance in Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Circ. Arrhythm. Electrophysiol., 14, e009343, 10.1161/CIRCEP.120.009343 Eisen, 2019, Electrophysiological abnormalities in induced pluripotent stem cell-derived cardiomyocytes generated from Duchenne muscular dystrophy patients, J. Cell Mol. Med., 23, 2125, 10.1111/jcmm.14124 Kawamura, 2012, Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model, Circulation, 126, S29, 10.1161/CIRCULATIONAHA.111.084343 Liew, 2020, Mending a broken heart: current strategies and limitations of cell-based therapy, Stem Cell Res. Ther., 11, 138, 10.1186/s13287-020-01648-0 Blinova, 2019, Clinical Trial in a Dish: Personalized Stem Cell–Derived Cardiomyocyte Assay Compared With Clinical Trial Results for Two QT-Prolonging Drugs, Clin. Transl. Sci., 12, 687, 10.1111/cts.12674 Strauss, 2017, Clinical Trials in a Dish, Trends Pharmacol. Sci., 38, 4, 10.1016/j.tips.2016.10.009 Ma, 2011, High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents, Am. J. Physiol. Heart Circ. Physiol., 301, H2006, 10.1152/ajpheart.00694.2011 Cyganek, 2018, Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes, JCI Insight, 3, e99941, 10.1172/jci.insight.99941 Herron, 2016, Extracellular Matrix-Mediated Maturation of Human Pluripotent Stem Cell-Derived Cardiac Monolayer Structure and Electrophysiological Function, Circ. Arrhythm. Electrophysiol., 9, e003638, 10.1161/CIRCEP.113.003638 Blinova, 2017, Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias, Toxicol. Sci., 155, 234, 10.1093/toxsci/kfw200 Block, 2020, Human perinatal stem cell derived extracellular matrix enables rapid maturation of hiPSC-CM structural and functional phenotypes, Sci. Rep., 10, 19071, 10.1038/s41598-020-76052-y Smith, 2020, NanoMEA: A Tool for High-Throughput, Electrophysiological Phenotyping of Patterned Excitable Cells, Nano Lett., 20, 1561, 10.1021/acs.nanolett.9b04152 Feaster, 2015, Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Circ. Res., 117, 995, 10.1161/CIRCRESAHA.115.307580 Dhahri, 2022, In Vitro Matured Human Pluripotent Stem Cell–Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts, Circulation, 145, 1412, 10.1161/CIRCULATIONAHA.121.053563 Kamakura, 2013, Ultrastructural Maturation of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Long-Term Culture, Circ. J., 77, 1307, 10.1253/circj.CJ-12-0987 Lundy, 2013, Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells, Stem Cell. Dev., 22, 1991, 10.1089/scd.2012.0490 Lewandowski, 2018, The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin, Cell Transplant., 27, 1047, 10.1177/0963689718779346 da Rocha, 2017, hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen, Sci. Rep., 7, 13834, 10.1038/s41598-017-13590-y Almeida, 2021, Human Extracellular-Matrix Functionalization of 3D hiPSC-Based Cardiac Tissues Improves Cardiomyocyte Maturation, ACS Appl. Bio Mater., 4, 1888, 10.1021/acsabm.0c01490 Ronaldson-Bouchard, 2018, Advanced maturation of human cardiac tissue grown from pluripotent stem cells, Nature, 556, 239, 10.1038/s41586-018-0016-3 Nunes, 2013, Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes, Nat. Methods, 10, 781, 10.1038/nmeth.2524 Herron, 2012, Optical imaging of voltage and calcium in cardiac cells & tissues, Circ. Res., 110, 609, 10.1161/CIRCRESAHA.111.247494 Gintant, 2020, Repolarization studies using human stem cell-derived cardiomyocytes: Validation studies and best practice recommendations, Regul. Toxicol. Pharmacol., 117, 104756, 10.1016/j.yrtph.2020.104756 Russell, 1959 Bers, 2002, Cardiac excitation–contraction coupling, Nature, 415, 198, 10.1038/415198a Veerman, 2015, Immaturity of Human Stem-Cell-Derived Cardiomyocytes in Culture: Fatal Flaw or Soluble Problem?, Stem Cell. Dev., 24, 1035, 10.1089/scd.2014.0533 Garg, 2018, Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes as Models for Cardiac Channelopathies, Circ. Res., 123, 224, 10.1161/CIRCRESAHA.118.311209 Inoue, 1991, Antiarrhythmic drugs preferentially produce conduction block at the area of slow conduction in the re-entrant circuit of canine atrial flutter: comparative study of disopyramide, flecainide, and E-4031, Cardiovasc. Res., 25, 223, 10.1093/cvr/25.3.223 Doss, 2012, Maximum Diastolic Potential of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Depends Critically on IKr, PLoS One, 7, e40288, 10.1371/journal.pone.0040288 Yu, 2009, Human induced pluripotent stem cells free of vector and transgene sequences, Science (New York, N.Y.), 324, 797, 10.1126/science.1172482 Reiser, 2001, Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles, Am. J. Physiol. Heart Circ. Physiol., 280, H1814, 10.1152/ajpheart.2001.280.4.H1814 Herron, 2007, Calcium-independent negative inotropy by beta-myosin heavy chain gene transfer in cardiac myocytes, Circ. Res., 100, 1182, 10.1161/01.RES.0000264102.00706.4e Nielsen, 2018, Biobank-driven genomic discovery yields new insight into atrial fibrillation biology, Nat. Genet., 50, 1234, 10.1038/s41588-018-0171-3 Fedida, 2007, Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent, Expet Opin. Invest. Drugs, 16, 519, 10.1517/13543784.16.4.519 Roy, 2008, Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation, Circulation, 117, 1518, 10.1161/CIRCULATIONAHA.107.723866 Chen, 2013, Ultrasensitive fluorescent proteins for imaging neuronal activity, Nature, 499, 295, 10.1038/nature12354 Nakai, 2001, A high signal-to-noise Ca(2+) probe composed of a single green fluorescent protein, Nat. Biotechnol., 19, 137, 10.1038/84397 Statzer, 2020, The extracellular matrix phenome across species, Matrix Biol., 8, 100039, 10.1016/j.mbplus.2020.100039 Sainio, 2020, Extracellular matrix-cell interactions: Focus on therapeutic applications, Cell. Signal., 66, 109487, 10.1016/j.cellsig.2019.109487 Saleem, 2020, Blinded, Multicenter Evaluation of Drug-induced Changes in Contractility Using Human-induced Pluripotent Stem Cell-derived Cardiomyocytes, Toxicol. Sci., 176, 103, 10.1093/toxsci/kfaa058 Goldfracht, 2020, Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes, Nat. Commun., 11, 75, 10.1038/s41467-019-13868-x Wettwer, 2013, The new antiarrhythmic drug vernakalant: ex vivo study of human atrial tissue from sinus rhythm and chronic atrial fibrillation, Cardiovasc. Res., 98, 145, 10.1093/cvr/cvt006 Qu, 2017, Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae, Front. Physiol., 8, 1109, 10.3389/fphys.2017.01109 Jiang, 2018, An Ultrasensitive Calcium Reporter System via CRISPR-Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells, iScience, 9, 27, 10.1016/j.isci.2018.10.007 Acharya, 2022, Live-Cell Imaging of the Contractile Velocity and Transient Intracellular Ca(2+) Fluctuations in Human Stem Cell-Derived Cardiomyocytes, Cells, 11, 1280, 10.3390/cells11081280 Shinnawi, 2015, Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters, Stem Cell Rep., 5, 582, 10.1016/j.stemcr.2015.08.009 Lou, 2012, Remodeling of calcium handling in human heart failure, Adv. Exp. Med. Biol., 740, 1145, 10.1007/978-94-007-2888-2_52 Morgan, 1990, Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure, Circulation, 81 Bedada, 2014, Acquisition of a quantitative, stoichiometrically conserved ratiometric marker of maturation status in stem cell-derived cardiac myocytes, Stem Cell Rep., 3, 594, 10.1016/j.stemcr.2014.07.012 Gu, 2021, Recent Advances in Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes Promoted by Mechanical Stretch, Med. Sci. Mon. Int. Med. J. Exp. Clin. Res., 27, e931063 Tzatzalos, 2016, Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies, Adv. Drug Deliv. Rev., 96, 234, 10.1016/j.addr.2015.09.010 Weinberger, 2017, Engineering Cardiac Muscle Tissue, Circ. Res., 120, 1487, 10.1161/CIRCRESAHA.117.310738 Chen, 2007, Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts, J. Bone Miner. Res., 22, 1943, 10.1359/jbmr.070725 Marinkovic, 2016, One size does not fit all: developing a cell-specific niche for in vitro study of cell behavior, Matrix Biol., 52–54, 426, 10.1016/j.matbio.2016.01.004 Lian, 2012, Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling, Proc. Natl. Acad. Sci. USA, 109, E1848, 10.1073/pnas.1200250109 Monteiro da Rocha, 2016, Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes, J. Mol. Cell. Cardiol., 99, 197, 10.1016/j.yjmcc.2016.09.004 Zhang, 2019, Functional cardiac fibroblasts derived from human pluripotent stem cells via second heart field progenitors, Nat. Commun., 10, 2238, 10.1038/s41467-019-09831-5 Lee, 2012, Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers, Circ. Res., 110, 1556, 10.1161/CIRCRESAHA.111.262535